Skip to main content
. 2026 Jan 30;18(3):448. doi: 10.3390/cancers18030448
BED Biologically effective dose
PTBE Peritumoral brain edema
LINAC Linear accelerator
SRS Stereotactic radiosurgery
hf-SRS Hypofractionated stereotactic radiosurgery
hf-SRT Hypofractionated stereotactic radiotherapy
GTV Gross tumor volume
CTV Clinical target volume
PTV Planning target volume
ROC Receiver operating characteristic
AUC Area under the curve
HR Hazard ratio
CI Confidence interval
WHO World Health Organization
BBB Blood–brain barrier
MRI Magnetic resonance imaging
CT Computed tomography
ANOVA Analysis of variance